The long road of long COVID: specific considerations for the allergist/immunologist

JA Bellanti, P Novak, Y Faitelson, JA Bernstein… - The Journal of Allergy …, 2023 - Elsevier
Long COVID (coronavirus disease 2019) syndrome, also known as post-acute sequelae of
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is a new disorder …

COVID-19 in children: Pathogenesis and current status.

LD Frenkel, F Gomez… - Allergy & Asthma …, 2021 - search.ebscohost.com
Background: Since its initial description in December 2019 in Wuhan, China, coronavirus
disease 2019 (COVID-19) has rapidly progressed into a worldwide pandemic, which has …

[HTML][HTML] COVID-19 in a patient with severe asthma using mepolizumab

K Aksu, S Yesilkaya, M Topel, S Turkyilmaz… - Allergy and asthma …, 2021 - ncbi.nlm.nih.gov
Background: There is a lack of information about the course of coronavirus disease 2019
(COVID-19) in patients with severe asthma who were treated with biologics. Some reports …

The immunologic response to severe acute respiratory syndrome coronavirus 2

NK Le, K Kaman, HC Martin, J Mullur… - Allergy and Asthma …, 2021 - ingentaconnect.com
Background: The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
has precipitated the worst global pandemic in a century, which has caused millions of …

Considerations for asthma management and viral transmission in the era of COVID-19

MM Pitlick, AY Joshi - Allergy and Asthma Proceedings, 2021 - ingentaconnect.com
Background: As the global COVID-19 pandemic has unfolded, there has been much debate
surrounding the optimal management of patients with asthma who are at risk of or contract …

The new frontier: Clinical consequences of long COVID

JA Bellanti - Journal of Precision Respiratory Medicine, 2023 - ingentaconnect.com
Background: After infection with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), a variety of clinical outcomes have been known to occur, ranging from asymptomatic …

[HTML][HTML] Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist

JA Bellanti, RA Settipane - Allergy and Asthma Proceedings, 2021 - ncbi.nlm.nih.gov
In previous issues of the Proceedings, several articles on coronavirus disease 2019 (COVID-
19) were published in response to a national crisis that continues to be a focus for clinical …

[HTML][HTML] The allergist/immunologist, the Janus gatekeeper of inflammation, COVID-19 and beyond

JA Bellanti, RA Settipane - Allergy and Asthma Proceedings, 2020 - ncbi.nlm.nih.gov
In ancient Rome, the Roman god Janus was often portrayed as having two faces: one
looking forward to the future, the other looking back over the past. Janus, however, had …

[HTML][HTML] Eosinophilic esophagitis: from discovery to effective treatment

JA Bellanti, RA Settipane - Allergy and Asthma Proceedings, 2022 - ncbi.nlm.nih.gov
This issue of the Proceedings addresses a broad spectrum of atopic conditions that focus,
first on the topic of eosinophilic esophagitis (EoE), a condition first reported by Landres et al …

[HTML][HTML] Asthma biomarkers and COVID-19 continue to dominate current medical issues

JA Bellanti, RA Settipane - Allergy and Asthma Proceedings, 2022 - ncbi.nlm.nih.gov
Asthma is one of the most widespread chronic health problems throughout the world and
affects; 26 million persons in the United States, and is a major focus of this issue, with six …